US Patent 10898476 Heat shock proteins and cholesterol homeostasis
Patent 10898476 was granted and assigned to Orphazyme on January, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+264 characters)
Article
Patent abstract
Provided herewith are bioactive agents that increase the intracellular concentration and/or activity of one or more heat shock proteins, including Hsp70, for use in the treatment of a disease associated with dysregulation of cholesterol homeostasis.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Burcin Gungor0
Elina Ikonen0
Thomas Kirkegaard Jensen0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
108984760
Date of Patent
January 26, 2021
0Patent Application Number
160932830
Date Filed
April 10, 2017
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10898476 Heat shock proteins and cholesterol homeostasis
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10898476
Date of patent
January 26, 2021
Patent application number
16093283
Date Filed
April 10, 2017
Patent primary examiner
Find more entities like US Patent 10898476 Heat shock proteins and cholesterol homeostasis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.